|71.54||+0.8400||+1.19%||Vol 44.17K||1Y Perf 281.85%|
|Sep 15th, 2021 16:00 DELAYED|
|- -%||- -|
|Target Price||90.20||Analyst Rating||Strong Buy 1.00|
|Potential %||26.08||Finscreener Ranking||★★★★ 53.58|
|Insiders Trans % 3/6/12 mo.||-100/-83/-96||Value Ranking||★★ 47.62|
|Insiders Value % 3/6/12 mo.||-100/-99/-100||Growth Ranking||★★ 45.81|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-98/-100||Income Ranking||— -|
|Price Range Ratio 52W %||76.27||Earnings Rating||Buy|
|Market Cap||1.70B||Earnings Date||8th Nov 2021|
Today's Price Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||8th Nov 2021|
|Estimated EPS Next Report||-0.34|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||84.20K|
|Avg. Monthly Volume||88.97K|
|Avg. Quarterly Volume||105.14K|
Establishment Labs Holdings Inc. (NASDAQ: ESTA) stock closed at 71.54 per share at the end of the most recent trading day (a 1.19% change compared to the prior day closing price) with a volume of 44.17K shares and market capitalization of 1.70B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 488 people. Establishment Labs Holdings Inc. CEO is Juan Jose Chacon Quiros.
The one-year performance of Establishment Labs Holdings Inc. stock is 281.85%, while year-to-date (YTD) performance is 90.06%. ESTA stock has a five-year performance of %. Its 52-week range is between 16.5 and 88.66, which gives ESTA stock a 52-week price range ratio of 76.27%
Establishment Labs Holdings Inc. currently has a PE ratio of -79.20, a price-to-book (PB) ratio of 25.14, a price-to-sale (PS) ratio of 15.07, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -13.96%, a ROC of -13.00% and a ROE of -28.58%. The company’s profit margin is -18.99%, its EBITDA margin is -7.50%, and its revenue ttm is $112.05 Million , which makes it $4.72 revenue per share.
Of the last four earnings reports from Establishment Labs Holdings Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.34 for the next earnings report. Establishment Labs Holdings Inc.’s next earnings report date is 08th Nov 2021.
The consensus rating of Wall Street analysts for Establishment Labs Holdings Inc. is Strong Buy (1), with a target price of $90.2, which is +26.08% compared to the current price. The earnings rating for Establishment Labs Holdings Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Establishment Labs Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Establishment Labs Holdings Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 31.32, ATR14 : 3.54, CCI20 : -60.32, Chaikin Money Flow : 0.00, MACD : -0.15, Money Flow Index : 45.92, ROC : -1.28, RSI : 46.09, STOCH (14,3) : 14.85, STOCH RSI : 0.17, UO : 42.36, Williams %R : -85.15), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Establishment Labs Holdings Inc. in the last 12-months were: Dennis Condon (Option Excercise at a value of $91 710), Dennis Condon (Sold 9 000 shares of value $711 132 ), Juan Jose Chacon Quiros (Sold 100 000 shares of value $3 498 982 ), Lisa Gersh (Option Excercise at a value of $365 800), Lisa Gersh (Sold 18 000 shares of value $1 270 051 ), Nicholas Lewin (Buy at a value of $20 990), Renee M. Gaeta (Option Excercise at a value of $9 171), Renee M. Gaeta (Sold 900 shares of value $66 844 ), Roberto De Mezerville (Sold 40 934 shares of value $1 826 940 ), Salvador Santos Dada (Sold 50 000 shares of value $1 944 520 )
Mon, 23 Aug 2021 14:05 GMT Analysts Top Healthcare Picks: Establishment Labs Holdings (ESTA), Dynavax (DVAX)- TipRanks. All rights reserved.
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.